Shanghai HeartCare Medical Technology Corporation Limited (HEARTCARE-B) aksje

Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices in Mainland China. The company offers thrombectomy stent, aspiration pump, and aspiration catheter products for the treatment of acute ischemic stroke; and intracranial drug-eluting stent, intracranial balloon dilatation catheter, intracranial low pressure balloon dilatation catheter, carotid artery balloon dilatation catheter, embolization protection system, and carotid artery stent products for the treatment of neurovascular stenosis. It also provides embolic coil, intracranial stent, neurovascular occlusion balloon system, and flow diverter devices for the treatment of hemorrhagic stroke; left atrial appendage occluder for the prevention of ischemic stroke; and peripheral interventional devices, including fibered occlusion coil, disposable venous ablation catheter, and peripheral thrombus AP catheter. In addition, the company provides neuro-interventional access devices, such as balloon guiding catheter, distal access catheter, microcatheter, microcatheter for coiling, microcatheter for flow diverter device, navigation catheter, vascular closure device, neuro-interventional micro, guidewire, support catheter, neuro-interventional microcatheter, radial access, catheter system, and neuro balloon delivery catheter; thrombectomy stent for the treatment of acute ischemic stroke; embolic coil for the treatment of hemorrhagic stroke. Shanghai HeartCare Medical Technology Corporation Limited was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.